$CRWDNeutralLow

GANDHI SAMEER K sold $157K of CRWD

GANDHI SAMEER K sold 206 shares of CrowdStrike Holdings, Inc. (CRWD) at $763.33 ($0.16M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

6/10
3/10
Low
Neutral
Filed June 3, covering a sale dated June 1
Neutral—insider selling can be read negatively, but 10b5-1 framing tempers impact

Insider selling disclosed on SEC Form 4; likely low signal given pre-arranged 10b5-1, but can marginally affect near-term sentiment.

CrowdStrike director Sameer K. Gandhi sold $157K of CRWD shares via an open-market transaction under a 10b5-1 plan.

Limited/short-lived impact; any move is more likely sentiment-driven than fundamentals.

Background

SEC Form 4 insider transaction disclosure for a director; includes trade date, share count, price, and whether it was under a pre-arranged 10b5-1 plan.

Why it matters

Traders may briefly reassess sentiment around CRWD, but the 10b5-1 designation typically lowers the probability of a meaningful fundamental read-through.

Market relevance

Routine insider selling disclosure; potential minor sentiment effect, low fundamental implication.

Market effects

Minimal; this is company-specific insider activity with no stated operational or regulatory catalyst.

None indicated.

None indicated.

Alternative perspectives

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

The transaction size ($157K) is small relative to CRWD’s market cap, and the filing provides no reason for the sale beyond the plan structure.

Key entities

  • CrowdStrike Holdings, Inc.

    Subject of the SEC Form 4 insider sale disclosed on June 3 (sale dated June 1).

  • GANDHI SAMEER K

    Director who executed an open-market sale of 206 CRWD shares under a 10b5-1 plan.

Related articles

$CRWDMed

Weakness May Be an Opportunity for CrowdStrike Stock

CrowdStrike said demand for its Falcon platform and broader security offerings remains strong as cybersecurity spending grows, including amid AI adoption, according to management. The company raised full-year ARR guidance to $6.53B–$6.56B and increased revenue and earnings guidance. Analysts: 34 “Strong Buy,” 3 “Moderate Buy,” 11 “Hold,” 2 “Strong Sell” (consensus “Moderate Buy”); mean target $723.74 and high $825.

$ZSMedAI 9/10

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Zscaler shares fell more than 31% after fiscal Q3 2026 results, despite revenue of $850M+ (+25% YoY vs. $835M est.) and adjusted EPS of $1.08 (+28% YoY vs. $1.01 est.). The company raised full-year revenue growth to 24.6%–24.7% but cut its free-cash-flow margin outlook (midpoint 26.75% to 23.1%) and guided 16%–17% ARR growth next year. CrowdStrike slipped about 7% after fiscal Q1 2027 beats and a raise; revenue was $1.39B (+26% YoY), EPS $1.10 (+51% YoY), and net new ARR growth guidance increase

$CRWDLow

Rosenblatt Lifts PT on CrowdStrike (CRWD) Following “Outstanding” Q1

Rosenblatt raised its CrowdStrike (CRWD) price target to $825 from $640 and kept a Buy rating after what it called an “outstanding” fiscal Q1. The firm said shares fell about 11% after hours, attributing it to profit taking after an ~87% post-earnings rise, and cited the “Mythos moment” and Falcon’s role in AI cybersecurity. Wedbush also raised its target to $720 from $700, maintaining Outperform.

$CRWDLow

Is CrowdStrike Stock a Buy on the Dip?

CrowdStrike shares fell after fiscal Q1 results, despite the company raising its full-year ARR growth outlook to 27%–29% from 23%–24%, according to the report. Ending ARR rose 24% to $5.51B and net new ARR 32% to $256M. Revenue grew 26% to $1.39B; adjusted EPS rose 51% to $1.10. Fiscal 2027 revenue guidance was $5.915B–$5.959B and adjusted EPS $4.88–$4.96.